140 related articles for article (PubMed ID: 15328153)
1. Enhancement of the host immune responses in cutaneous T-cell lymphoma by CpG oligodeoxynucleotides and IL-15.
Wysocka M; Benoit BM; Newton S; Azzoni L; Montaner LJ; Rook AH
Blood; 2004 Dec; 104(13):4142-9. PubMed ID: 15328153
[TBL] [Abstract][Full Text] [Related]
2. Synthetic imidazoquinolines potently and broadly activate the cellular immune response of patients with cutaneous T-cell lymphoma: synergy with interferon-gamma enhances production of interleukin-12.
Wysocka M; Newton S; Benoit BM; Introcaso C; Hancock AS; Chehimi J; Richardson SK; Gelfand JM; Montaner LJ; Rook AH
Clin Lymphoma Myeloma; 2007 Sep; 7(8):524-34. PubMed ID: 18021470
[TBL] [Abstract][Full Text] [Related]
3. Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-γ: implications for therapy of cutaneous T-cell lymphoma.
Wysocka M; Dawany N; Benoit B; Kossenkov AV; Troxel AB; Gelfand JM; Sell MK; Showe LC; Rook AH
Leuk Lymphoma; 2011 Oct; 52(10):1970-9. PubMed ID: 21942329
[TBL] [Abstract][Full Text] [Related]
4. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
Merlo A; Calcaterra C; Mènard S; Balsari A
J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
[TBL] [Abstract][Full Text] [Related]
6. CpG-oligodeoxynucleotides enhance T-cell receptor-triggered interferon-gamma production and up-regulation of CD69 via induction of antigen-presenting cell-derived interferon type I and interleukin-12.
Kranzer K; Bauer M; Lipford GB; Heeg K; Wagner H; Lang R
Immunology; 2000 Feb; 99(2):170-8. PubMed ID: 10692033
[TBL] [Abstract][Full Text] [Related]
7. IL-21 enhances antitumor responses without stimulating proliferation of malignant T cells of patients with Sézary syndrome.
Yoon JS; Newton SM; Wysocka M; Troxel AB; Hess SD; Richardson SK; Lin JH; Benoit BM; Kasprzycka M; Wasik MA; Rook AH
J Invest Dermatol; 2008 Feb; 128(2):473-80. PubMed ID: 17713571
[TBL] [Abstract][Full Text] [Related]
8. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.
Ballas ZK; Rasmussen WL; Krieg AM
J Immunol; 1996 Sep; 157(5):1840-5. PubMed ID: 8757300
[TBL] [Abstract][Full Text] [Related]
9. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of T-cell activation and natural killer cell antigens indicates systemic anti-tumor response in early primary cutaneous T-cell lymphoma.
Asadullah K; Friedrich M; Döcke WD; Jahn S; Volk HD; Sterry W
J Invest Dermatol; 1997 May; 108(5):743-7. PubMed ID: 9129226
[TBL] [Abstract][Full Text] [Related]
11. FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function.
Chen W; Chan AS; Dawson AJ; Liang X; Blazar BR; Miller JS
Biol Blood Marrow Transplant; 2005 Jan; 11(1):23-34. PubMed ID: 15625541
[TBL] [Abstract][Full Text] [Related]
12. Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals.
Martinson JA; Tenorio AR; Montoya CJ; Al-Harthi L; Gichinga CN; Krieg AM; Baum LL; Landay AL
Immunology; 2007 Apr; 120(4):526-35. PubMed ID: 17343615
[TBL] [Abstract][Full Text] [Related]
13. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.
Hornung V; Rothenfusser S; Britsch S; Krug A; Jahrsdörfer B; Giese T; Endres S; Hartmann G
J Immunol; 2002 May; 168(9):4531-7. PubMed ID: 11970999
[TBL] [Abstract][Full Text] [Related]
14. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells.
Krug A; Rothenfusser S; Hornung V; Jahrsdörfer B; Blackwell S; Ballas ZK; Endres S; Krieg AM; Hartmann G
Eur J Immunol; 2001 Jul; 31(7):2154-63. PubMed ID: 11449369
[TBL] [Abstract][Full Text] [Related]
15. The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patients.
Kelly-Sell MJ; Kim YH; Straus S; Benoit B; Harrison C; Sutherland K; Armstrong R; Weng WK; Showe LC; Wysocka M; Rook AH
Am J Hematol; 2012 Apr; 87(4):354-60. PubMed ID: 22367792
[TBL] [Abstract][Full Text] [Related]
16. Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity.
Suzuki Y; Wakita D; Chamoto K; Narita Y; Tsuji T; Takeshima T; Gyobu H; Kawarada Y; Kondo S; Akira S; Katoh H; Ikeda H; Nishimura T
Cancer Res; 2004 Dec; 64(23):8754-60. PubMed ID: 15574787
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells, macrophages, NK and CD8
Lucinda N; Figueiredo MM; Pessoa NL; Santos BS; Lima GK; Freitas AM; Machado AM; Kroon EG; Antonelli LR; Campos MA
Virol J; 2017 Feb; 14(1):37. PubMed ID: 28222752
[TBL] [Abstract][Full Text] [Related]
18. Circulating natural killer lymphocytes are potential cytotoxic effectors against autologous malignant cells in sezary syndrome patients.
Bouaziz JD; Ortonne N; Giustiniani J; Schiavon V; Huet D; Bagot M; Bensussan A
J Invest Dermatol; 2005 Dec; 125(6):1273-8. PubMed ID: 16354199
[TBL] [Abstract][Full Text] [Related]
19. Interaction of cutaneous lymphoma cells with reactive T cells and dendritic cells: implications for dendritic cell-based immunotherapy.
Thumann P; Lüftl M; Moc I; Bagot M; Bensussan A; Schuler G; Jenne L
Br J Dermatol; 2003 Dec; 149(6):1128-42. PubMed ID: 14674889
[TBL] [Abstract][Full Text] [Related]
20. Distinct CpG oligonucleotide sequences activate human gamma delta T cells via interferon-alpha/-beta.
Rothenfusser S; Hornung V; Krug A; Towarowski A; Krieg AM; Endres S; Hartmann G
Eur J Immunol; 2001 Dec; 31(12):3525-34. PubMed ID: 11745372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
